Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Griffiths

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Adicciones|April 18, 2012
Reducing drug related mortality in Europe - a seemingly intractable public health issueIsabelle Giraudon, Julian Vicente, João Matias, et al.
Addiction (Abingdon, England)|May 5, 2011
Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)Paul Griffiths, Jane Mounteney, Dominique Lopez, et al.
Clinical Medicine (London, England)|April 30, 2011
Implementing an interprofessional patient recordPaul Griffiths, Alan Anderson, Clare Coyne, et al.
European Journal of Pain (London, England)|January 11, 2021
Is Europe facing an opioid epidemic: What does European monitoring data tell us?Thomas Seyler, Isabelle Giraudon, André Noor, et al.
The Journal of Infectious Diseases|March 1, 2019
Original Antigenic Sin Shapes the Immunological Repertoire Evoked by Human Cytomegalovirus Glycoprotein B/MF59 Vaccine in Seropositive RecipientsIlona Baraniak, Florian Kern, Pavlo Holenya, et al.
Addiction (Abingdon, England)|April 3, 2024
Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countriesAlexander Soderholm, David Mansfield, Teodora Groshkova, et al.
Drug and Alcohol Review|May 15, 2003
The monitoring of drug trends in AustraliaFiona Shand, Libby Topp, Shane Darke, et al.
Proteomics|February 1, 2014
Compound heterozygotes and beta-thalassemia: top-down mass spectrometry for detection of hemoglobinopathiesRebecca L Edwards, Paul Griffiths, Josephine Bunch, et al.
Drug and Alcohol Review|October 4, 2017
Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studiesLucas Wiessing, Marica Ferri, Shane Darke, et al.
Addiction (Abingdon, England)|November 21, 2017
Looking to the future-more concern than optimism that cryptomarkets will reduce drug-related harmsJane Mounteney, Andrew Cunningham, Teodora Groshkova, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Adicciones|April 18, 2012
Reducing drug related mortality in Europe - a seemingly intractable public health issueIsabelle Giraudon, Julian Vicente, João Matias, et al.
Addiction (Abingdon, England)|May 5, 2011
Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)Paul Griffiths, Jane Mounteney, Dominique Lopez, et al.
Clinical Medicine (London, England)|April 30, 2011
Implementing an interprofessional patient recordPaul Griffiths, Alan Anderson, Clare Coyne, et al.
European Journal of Pain (London, England)|January 11, 2021
Is Europe facing an opioid epidemic: What does European monitoring data tell us?Thomas Seyler, Isabelle Giraudon, André Noor, et al.
The Journal of Infectious Diseases|March 1, 2019
Original Antigenic Sin Shapes the Immunological Repertoire Evoked by Human Cytomegalovirus Glycoprotein B/MF59 Vaccine in Seropositive RecipientsIlona Baraniak, Florian Kern, Pavlo Holenya, et al.
Addiction (Abingdon, England)|April 3, 2024
Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countriesAlexander Soderholm, David Mansfield, Teodora Groshkova, et al.
Drug and Alcohol Review|May 15, 2003
The monitoring of drug trends in AustraliaFiona Shand, Libby Topp, Shane Darke, et al.
Proteomics|February 1, 2014
Compound heterozygotes and beta-thalassemia: top-down mass spectrometry for detection of hemoglobinopathiesRebecca L Edwards, Paul Griffiths, Josephine Bunch, et al.
Drug and Alcohol Review|October 4, 2017
Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studiesLucas Wiessing, Marica Ferri, Shane Darke, et al.
Addiction (Abingdon, England)|November 21, 2017
Looking to the future-more concern than optimism that cryptomarkets will reduce drug-related harmsJane Mounteney, Andrew Cunningham, Teodora Groshkova, et al.
Pageof 19